ADVMExpecting ADVM to stay above this zone and presumably hit the first pt which is the dashed line at $1.66 with the final pt at $1.75
ADVM
ADVM Technical Analysis 🧙Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durability with treatment response, reduce the treatment burden of frequent anti-vascular endothelial growth factor (anti-VEGF) injections, and improve real-world vision outcomes for patients.
Adverum Biotechnologies Inc 🧙Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durability with treatment response, reduce the treatment burden of frequent anti-vascular endothelial growth factor (anti-VEGF) injections, and improve real-world vision outcomes for patients.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ADVM - Long Setup Watch for a break of 3.80 Stop signal 3.43. First target 4.43., Second target Momentum
ADVM Technical Analysis 🧙Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durability with treatment response, reduce the treatment burden of frequent anti-vascular endothelial growth factor (anti-VEGF) injections, and improve real-world vision outcomes for patients.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Big Drop or some what of drop?This will be a good stock to look in the morning at open if you're the type to short stocks.ADVM had some great gains today because they had news released this morning. These penny stocks usually tend to move up for any reason and then drop the next day. On top of that it has also hit some resistance.ADVM will be worth to look at tomorrow morning at open.
Quote: “When I became a winner, I said, ‘I figured it out, but if I’m wrong, I’m getting the hell out, because I want to save my money and go on to the next trade.’” – Marty Schwartz
Trader Essentials from Amazon
1. amzn.to -Tylenol Extra Strength Rapid Release (LOL)
2. amzn.to -Encyclopedia of Chart Patterns
3. amzn.to -Apple MacBook Pro
4. amzn.to -OLLY Goodbye Stress Gummy,
ADVM30 min chart, possible upward movement this morning as MACD closes in to cross. - Will watch this as market opens.
RSI seems to be perking up and showing signs of upward movement.
